Genetic testing in young women with breast cancer: Results from a Web-based survey

Annals of Oncology

Volumn 21, Issue 4, 2009, Pages 741-747

  Ruddy, K J ^a   Gelber, S ^a   Shin, J ^b   Garber, J E ^a   Rosenberg, R ^c   Przypysny, M ^c   Partridge, A H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Advocacy Young Survival Coalition   (United States)

Author keywords

BRCA1; BRCA2; Breast neoplasms; Female; Genetic counseling; Genetic polymorphism

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER DIAGNOSIS; CANCER SURVIVOR; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HEALTH SURVEY; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MASTECTOMY; OVARY CANCER; PATIENT ADVOCACY; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGE OF ONSET; BREAST NEOPLASMS; CARCINOMA; DATA COLLECTION; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INTERNET; MUTATION; RISK FACTORS; YOUNG ADULT;

EID: 77951945332     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp355     Document Type: Article

References (23)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57(1): 43-66.
2. Malone KE, Daling JR, Neal C et al. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 2000; 88(6): 1393-1402.
3. de Sanjose S, Leone M, Berez V et al. Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study. Int J Cancer 2003; 106(4): 588-593.
4. Goldberg JI, Borgen PI. Breast cancer susceptibility testing: past, present and future. Expert Rev Anticancer Ther 2006; 6(8): 1205-1214.
5. Kuhl CK, Schrading S, Leutner CC et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005; 23(33): 8469-8476.
6. Metcalfe KA, Lynch HT, Ghadirian P et al. The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. Gynecol Oncol 2005; 96(1): 222-226.
7. Metcalfe K, Lynch HT, Ghadirian P et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 2004; 22(12): 2328-2335.
8. FitzGerald MG, MacDonald DJ, Krainer M et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 1996; 334(3): 143-149.
9. Nusbaum R, Isaacs C. Management updates for women with a BRCA1 or BRCA2 mutation. Mol Diagn Ther 2007; 11(3): 133-144.
10. Rosenberg R, Levy-Schwartz R. Breast cancer in women younger than 40 years. Int J Fertil Womens Med 2003; 48(5): 200-205.
11. Partridge AH, Gelber S, Peppercorn J et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 2004; 2(20): 4174-4183.
12. Leining MG, Gelber S, Rosenberg R et al. Menopausal-type symptoms in young breast cancer survivors. Ann Oncol 2006; 17(12): 1777-1782.
13. Partridge A, Gelber S, Peppercorn J et al. Fertility and menopausal outcomes in young breast cancer survivors. Clin Breast Cancer 2008; 8: 65-69.
14. Lasry JC, Margolese RG. Fear of recurrence, breast-conserving surgery, and the trade-off hypothesis. Cancer 1992; 69(8): 2111-2115.
15. Spinhoven P, Ormel J, Sloekers PP et al. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997; 27(2): 363-370.
16. Nicoletto MO, Donach M, De Nicolo A et al. BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling. Cancer Treat Rev 2001; 27(5): 295-304.
17. Armstrong K, Weber B, Ubel PA et al. Interest in BRCA1/2 testing in a primary care population. Prev Med 2002; 34(6): 590-595.
18. Armstrong K, Micco E, Carney A et al. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 2005; 293(14): 1729-1736.
19. Brown KL, Hutchison R, Zinberg RE, McGovern MM. Referral and experience with genetic testing among women with early onset breast cancer. Genet Test 2005; 9(4): 301-305.
20. Schwartz MD, Lerman C, Brogan B et al. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiol Biomarkers Prev 2005; 14(4): 1003-1007.
21. O'Neill SM, Peters JA, Vogel VG et al. Referral to cancer genetic counseling: are there stages of readiness? Am J Med Genet C Semin Med Genet 2006; 142(4): 221-231.
22. Lerman C, Croyle R. Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med 1994; 154(6): 609-616.
23. Croyle RT, Smith KR, Botkin JR et al. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol 1997; 16(1): 63-72.